个性化文献订阅>期刊> ACS Medicinal Chemistry Letters
 

A Novel (18)F-Labeled Imidazo[2,1-b]benzothiazole (IBT) for High-Contrast PET Imaging of beta-Amyloid Plaques

  作者 YOUSEFI BEHROOZ H; DRZEZGA ALEXANDER; VON REUTERN BORIS; MANOOK ANDRE; SCHWAIGER MARKUS; WESTER HANSJUERGEN; HENRIKSEN GJERMUND  
  选自 期刊  ACS Medicinal Chemistry Letters;  卷期  2011年2-9;  页码  673-677  
  关联知识点  
 

[摘要](18)F-labeled imidazo[2,1-b]benzothiazole ([(18)F]8) was synthesized and evaluated as a tracer for cerebral beta-amyloid deposits (A beta) by means of positron emission tomography (PET). [(18)F]8 exhibits a high affinity to A beta and suitable brain uptake kinetics combined with a high metabolic stability in the brain. In a double transgenic APP/PS1 mouse model of Alzheimer's disease, we demonstrated a specific uptake of [(18)F]8 in A beta-containing telencephalic brain regions. The specific binding of [(18)F]8 to A beta was confirmed by regional brain biodistribution and autoradiography and correlated to immunohistochemistry staining. Analysis of brain sections of APP/PS1 mouse injected with a cocktail of [(18)F]8 and reference compound [(3)H]PiB revealed that the two tracers bind to A beta plaques in the brain of mouse in a comparable binding pattern. [(18)F]8 represents the first high-contrast PET imaging agent for detection of A beta plaques in transgenic mouse model of Alzheimer's disease and holds promise for transfer to a clinical evaluation.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内